These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38556865)

  • 1. Factors associated with electrocardiographic left ventricular hypertrophy among patients with hypertension in Thailand.
    Sakboonyarat B; Poovieng J; Rangsin R
    Clin Hypertens; 2024 Apr; 30(1):8. PubMed ID: 38556865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic left ventricular hypertrophy and mortality in an oldest-old hypertensive Chinese population.
    Chen R; Bai K; Lu F; Zhao Y; Pan Y; Wang F; Zhang L
    Clin Interv Aging; 2019; 14():1657-1662. PubMed ID: 31571845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure.
    Okin PM; Wachtell K; Gerdts E; Dahlöf B; Devereux RB
    J Hypertens; 2014 Dec; 32(12):2472-8; discussion 2478. PubMed ID: 25340854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and associated factors of electrocardiographic left ventricular hypertrophy in a rural community, central Thailand.
    Viwatrangkul P; Lawanwisut S; Leekhaphan P; Prasart-Intara T; Phiensuparp P; Prakiatpongsa S; Amnaj P; Phoominart V; Chanyou K; Jiratrakan P; Klumnaimueang P; Pipitdaecha N; Panchamawat R; Tangkongpanich P; Mungthin M; Rangsin R; Sakboonyarat B
    Sci Rep; 2021 Mar; 11(1):7083. PubMed ID: 33782536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale Monferrato Study.
    Bruno G; Giunti S; Bargero G; Ferrero S; Pagano G; Perin PC
    Diabet Med; 2004 Aug; 21(8):823-8. PubMed ID: 15270784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Dahlöf B
    Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT).
    Ruggenenti P; Iliev I; Costa GM; Parvanova A; Perna A; Giuliano GA; Motterlini N; Ene-Iordache B; Remuzzi G;
    Diabetes Care; 2008 Aug; 31(8):1629-34. PubMed ID: 18443191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelations Between Hypertension and Electrocardiographic Left Ventricular Hypertrophy and Their Associations With Cardiovascular Mortality.
    Cao X; Broughton ST; Waits GS; Nguyen T; Li Y; Soliman EZ
    Am J Cardiol; 2019 Jan; 123(2):274-283. PubMed ID: 30390988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of electrocardiographic left ventricular hypertrophy with incident cardiovascular disease in Japanese older hypertensive patients.
    Edison ES; Yano Y; Hoshide S; Kario K
    Am J Hypertens; 2015 Apr; 28(4):527-34. PubMed ID: 25267736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of left ventricular hypertrophy associated with type-2 diabetes in Shiraz, Iran: a cross-sectional study.
    Parsa N; Moheb M; Zibaeenezhad MJ; Karimi-Akhormeh A; Trevisan M; Wallin L; Zaheri PM; Sayadi M; Razeghian-Jahromi I; Moaref A
    BMC Cardiovasc Disord; 2023 Feb; 23(1):88. PubMed ID: 36792995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelation Between Electrocardiographic Left Atrial Abnormality, Left Ventricular Hypertrophy, and Mortality in Participants With Hypertension.
    Ahmad MI; Mujtaba M; Anees MA; Li Y; Soliman EZ
    Am J Cardiol; 2019 Sep; 124(6):886-891. PubMed ID: 31324356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol consumption and electrocardiographic left ventricular hypertrophy and mediation by elevated blood pressure in older Chinese men: the Guangzhou Biobank Cohort Study.
    Long MJ; Jiang CQ; Lam TH; Lin JM; Chan YH; Zhang WS; Jin YL; Liu B; Thomas GN; Cheng KK
    Alcohol; 2013 Sep; 47(6):473-80. PubMed ID: 23938170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM; Devereux RB; Gerdts E; Snapinn SM; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Lindholm LH; Dahlöf B;
    Circulation; 2006 Mar; 113(12):1588-96. PubMed ID: 16534012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic and Electrocardiographic Abnormalities Among Elderly Adults With Cardiovascular Disease in Rural South Africa.
    Ferro EG; Abrahams-Gessel S; Jardim TV; Wagner R; Gomez-Olive FX; Wade AN; Peters F; Tollman S; Gaziano TA
    Circ Cardiovasc Qual Outcomes; 2021 Nov; 14(11):e007847. PubMed ID: 34784231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania.
    Lutale JJ; Thordarson H; Gulam-Abbas Z; Vetvik K; Gerdts E
    Cardiovasc J Afr; 2008; 19(1):8-14. PubMed ID: 18320079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.
    Bang CN; Soliman EZ; Simpson LM; Davis BR; Devereux RB; Okin PM;
    Am J Hypertens; 2017 Sep; 30(9):914-922. PubMed ID: 28430947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography.
    Petersen SS; Pedersen LR; Pareek M; Nielsen ML; Diederichsen SZ; Leósdóttir M; Nilsson PM; Diederichsen AC; Olsen MH
    Blood Press; 2017 Feb; 26(1):54-63. PubMed ID: 27662908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.